Boccia RV - Search Results

1

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.

Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM; Sancuso Study Group. Boccia RV, et al. Support Care Cancer. 2011 Oct;19(10):1609-17. doi: 10.1007/s00520-010-0990-y. Epub 2010 Sep 12. Support Care Cancer. 2011. PMID: 20835873 Free PMC article. Clinical Trial.

2

Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy.

Boccia RV, Clark G, Howell JD. Boccia RV, et al. Cancer Manag Res. 2012;4:171-6. doi: 10.2147/CMAR.S31349. Epub 2012 Jul 3. Cancer Manag Res. 2012. PMID: 22904638 Free PMC article.

3

Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial.

Boccia R, Grunberg S, Franco-Gonzales E, Rubenstein E, Voisin D. Boccia R, et al. Support Care Cancer. 2013 May;21(5):1453-60. doi: 10.1007/s00520-012-1691-5. Epub 2013 Jan 26. Support Care Cancer. 2013. PMID: 23354552 Free PMC article. Clinical Trial.

4

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, Johnston MA, Steiner MS. Dobs AS, et al. Among authors: boccia rv. Lancet Oncol. 2013 Apr;14(4):335-45. doi: 10.1016/S1470-2045(13)70055-X. Epub 2013 Mar 14. Lancet Oncol. 2013. PMID: 23499390 Free PMC article. Clinical Trial.

5

Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial.

Raftopoulos H, Cooper W, O'Boyle E, Gabrail N, Boccia R, Gralla RJ. Raftopoulos H, et al. Support Care Cancer. 2015 Mar;23(3):723-32. doi: 10.1007/s00520-014-2400-3. Epub 2014 Sep 2. Support Care Cancer. 2015. PMID: 25179689 Free PMC article. Clinical Trial.

6

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials.

Gabrail N, Yanagihara R, Spaczyński M, Cooper W, O'Boyle E, Smith C, Boccia R. Gabrail N, et al. Cancer Manag Res. 2015 Mar 17;7:83-92. doi: 10.2147/CMAR.S72626. eCollection 2015. Cancer Manag Res. 2015. PMID: 25834466 Free PMC article.

7

Sustained antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of emetogenic chemotherapy.

Boccia R, Cooper W, O'Boyle E. Boccia R, et al. J Community Support Oncol. 2015 Feb;13(2):38-46. doi: 10.12788/jcso.0107. J Community Support Oncol. 2015. PMID: 25866983

8

Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.

Raftopoulos H, Boccia R, Cooper W, O'Boyle E, Gralla RJ. Raftopoulos H, et al. Future Oncol. 2015 Sep;11(18):2541-51. doi: 10.2217/fon.15.185. Epub 2015 Aug 20. Future Oncol. 2015. PMID: 26289588 Clinical Trial.

9

Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy.

Boccia R, O'Boyle E, Cooper W. Boccia R, et al. BMC Cancer. 2016 Feb 26;16:166. doi: 10.1186/s12885-016-2186-4. BMC Cancer. 2016. PMID: 26921245 Free PMC article. Clinical Trial.

10

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.

Garcia-Manero G, Montalban-Bravo G, Berdeja JG, Abaza Y, Jabbour E, Essell J, Lyons RM, Ravandi F, Maris M, Heller B, DeZern AE, Babu S, Wright D, Anz B, Boccia R, Komrokji RS, Kuriakose P, Reeves J, Sekeres MA, Kantarjian HM, Ghalie R, Roboz GJ. Garcia-Manero G, et al. Cancer. 2017 May 15;123(6):994-1002. doi: 10.1002/cncr.30533. Epub 2017 Jan 17. Cancer. 2017. PMID: 28094841 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters